Overview
- 33 inspections across 33 sites are on record.
- 41 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-06.
At a glance
Inspections
33
Sites
33
Observations
41
Career since
Aug 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Alcami Carolinas Corporation | 6 Feb 2026 | Human Drugs | View 483 → |
| Sekisui Medical Co., Ltd. | 21 Nov 2025 | Human Drugs | On file |
| Asahi Kasei Finechem Co., Ltd. | 14 Nov 2025 | Human Drugs | On file |
| Sumika Chemical Analysis Service, Ltd. | 7 Nov 2025 | Human Drugs | |
| Nanhai Beisha Pharmaceutical Co., Ltd. | 19 Sep 2025 | Human Drugs | On file |
Sites inspected
Alcami Carolinas CorporationCharleston, United States1 insp.
Sekisui Medical Co., Ltd.Hachimantai, Japan1 insp.
Asahi Kasei Finechem Co., Ltd.Nobeoka, Japan1 insp.
Sumika Chemical Analysis Service, Ltd.Oita, Japan1 insp.
Nanhai Beisha Pharmaceutical Co., Ltd.Nanhai, Foshan, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Evan Tong3 shared
Monica E Murie3 shared
Jenny Sung2 shared
Cynthia Jim2 shared
Amatul H Marium2 shared
Anthony J Donato2 shared
Robin P Mathew2 shared
Brandy N Lepage1 shared
Emmanuel J Ramos1 shared
JoshRenzo N Ramilo1 shared
Full investigator report
Get the verbatim findings behind Victoria Spivak's 41 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site